Stem Cell Companies

BioMimetic Therapeutics (BMTI)
Cytori Therapeutics (CYTX)
RTI Biologics (RTIX)
Aastrom Biosciences (ASTM)Stem Cell Stocks
Mesoblast (MBLTY)
Neuralstem (CUR)
Osteotech (OSTE)
ThermoGenesis (KOOL)
RegeneRx Biopharma (RGN)
Advanced Cell Tecchology (ACTC)
Pluristem Therapeutics (PSTI)
Athersys (ATHX)
International Stem Cell Corp (ISCO)
Stem Cell Innovations (SCLL)
Bioheart (BHRT)
CellCyte Genetics Corp (CCYG)
Stem Cell Therapeutics (SCTPF)
Brainstorm Cell Therapeutics (BCLI)
Opexa Therapeutics (OPXA)
Stem Cell Authority (SCAL)
Neostem (NBS)
Stem Cell Therapy Internt'l (SCII)
Cord Blood America (CBAI)
MultiCell Technologies (MCET)
LifeStem International (LSTM)

after almost a decade of limiting taxpayer money for research president Barrack Obama has lifted the restrictions on federal funding of human embryonic stem cell research today.

Back in 2001 George W. Bush restricted funding stem cell research to only a few stem cells that had been created prior to Aug. 9, 2001. This decision was based on politics and religion rather than science. Since then the rest of the world has taken a huge step forward in understanding and bringing commercial products closer to the market than the U.S.

For those unaware embryonic stem cells are pluripotent, meaning they have the ability to form into any cell type that make up the human body. Scientists across the globe (except the U.S.) hope to utilize them to regenerate brain cells lost in Parkinson's, repairing spinal cord injuries as well as treating diabetes, cancer, heart disease, multiple sclerosis and many more defects. Stem cells also help in understanding the human development and growth of diseases. If scientists can map the growth of a disease they will have a greater chance at forming treatments.

Let's think of how many Americans are suffering from the aforementioned ailments and what this research can do for them. I'm sure everyone reading this knows someone important to them that is affected by one of these maladies. Research in the U.S.has not progressed since earlier this decade, cures are a very long time away and lets not even discuss the approval requirement by the FDA. At least this can be seen as a huge step forward to join the rest of the world at bringing about cures that could help millions of people including you and I some day.

What is the merit of umbilical cord blood?
Umbilical cord blood contains very valuable cells; stem cells which can multiply and grow into cells which can cure serious and sometimes deadly diseases. They are used to combat more than 70 different diseases and research into new applications is continuously increasing; at present, more than 3,000 clinical studies are in progress. The blood and the stem cells are analyzed and processed using advanced technology and subsequently stored in the gas phase of liquid nitrogen. When needed, the cells can be used immediately.
Private versus public storage?
As a parent, you can have the umbilical cord blood with the stem cells of your child stored in the private or family blood bank. The stem cells are then available for later use and guarantee an exact match for the child concerned, and 25% chance that they are also an exact match for a brother or sister. Worldwide, hundreds of thousands of parents already decided to store the stem cells from the umbilical cord blood of their children in a private bank.
When the choice is public storage, the parents decide to make the stem cells available to others. The cells can then be utilized to save the life of another, unknown person, who shows a match with the donor blood. However, the donor parents do not have any guarantee that the stem cells remain available for their own child as well. In addition, it turns out that only 30 to 50% of all donations are indeed stored. The rest is destroyed. You will only get the guarantee that the stem cells are available if your child needs them by storing in a private or family bank.

DiggDigg   | RedditReddit   | Add to Mixx!MixxDeldel.icio.usStumble Stumble it!Bookmark and Share Share it

 
Name  
Comment
Verification Code code

Comments submitted from other visitors

Name :

???

Comment:

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>hi

More posts, Page # :

1 

More articles Cell Therapeutics, Inc

More articles Stem Cell Companies

More articles Stem Cell Stocks

More articles BioMimetic Therapeutics (BMTI)

More articles Pluristem Therapeutics-PTSI

More articles Osiris Therapeutics-OSIR

More articles Cytori Therapeutics, Inc.

More articles ThermoGenesis (KOOL)

More articles Nutra Pharma (OTCBB:NPHC)

More articles Human Embryonic Stem Cell Market

More articles RTI Biologics (RTIX)

More articles Aastrom Biosciences -ASTM



XOMA 052 Designated Orphan Drug by FDA ...
Published:Wed, 04 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, ......
XOMA to Announce 2010 Second Quarter Fi...
Published:Mon, 02 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, Augus......
XOMA 052 Orphan Drug Designation for Be...
Published:Thu, 29 Jul 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medic......
Biotech Stocks: Depomed, Dendreon lead ...
Published:Wed, 04 Aug 2010 07:55:59 -0700
Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.......
Trader Favorite Dendreon Spikes On Prov...
Published:Wed, 04 Aug 2010 08:00:00 -0700
After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales fi......
© 2010 | Privacy Policy | Powered By Noomle.com | SiteMap